Cenduit to Showcase Industry Solutions and Expertise at IRT 2016
Presentation to Highlight Capabilities for Intelligent Clinical Supply Forecasting and Simulations through IRT
Cenduit, a joint venture between QuintilesIMS and Thermo Fisher Scientific, is showcasing its solutions and expertise as the largest IRT specialist in the world at IRT 2016 — Interactive Response Technologies in Clinical Trials, October 25-26, 2016 in Philadelphia.
Cenduit’s Senior Director of Project Management Stefan Dürr will be representing Cenduit as a speaker during the conference, discussing the capabilities and expertise required for “Intelligent Clinical Supply Forecasting and Simulations through IRT.” Dürr will also share insights on recent trends, challenges and opportunities surrounding simulation and real-time forecasting for clinical trials through IRT.
Stefan Dürr, senior director of project management, Cenduit
Tuesday, October 25, 2016 at 5:15 p.m.
Hilton Philadelphia at Penn's Landing
201 S. Christopher Columbus Blvd.
Philadelphia, PA 19106
For media inquiries, please contact Ryan Boger at Largemouth Communications, (919) 459-6480, email@example.com.
Cenduit, a joint venture between Quintiles and Thermo Fisher Scientific, is the largest IRT specialist in the world with the expertise to empower sponsors for success by implementing a completely personalized system that puts them in control of their clinical trials. With the needs of investigator sites and patients top of mind, Cenduit offers clinical supply chain intelligence and clinical operations know-how through its IRT-driven services: patient randomization, patient reminders, drug supply management, and eClinical integration. Cenduit has offices in the US, UK, Switzerland, India, and Japan, and global clinical trial experience in more than 100 countries, interacting with more than 600,000 patients at more than 32,000 sites. For additional information, visit Cenduit online at www.cenduit.com; on Twitter @CenduitLLC or on LinkedIn at www.LinkedIn.com/Company/Cenduit.